跳至主要内容
临床试验/ISRCTN12365646
ISRCTN12365646已完成不适用

The effects of low dose 1,25-dihydroxyvitamin D3 on the polarising of cellular immune reactivity towards type two immunity

VU University Medical Center (The Netherlands)0 个研究点目标入组 24 人开始时间: 2006年12月28日最近更新:

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
24

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

性别
Female

入选标准

  • 1. Written informed consent
  • 2. Women, aged 20 to 30 years
  • 3. Use of oral contraception with estrogen and progestin
  • 4. Apparently healthy

排除标准

  • 2. Pregnancy
  • 3. Smoking
  • 4. Alcohol abuse: more than 3 Units/day
  • 5. Use of drugs, except for incidental analgesic agents
  • 6. Use of diuretic medication or corticosteroids
  • 7. Auto immune diseases
  • 8. Renal impairment (serum creatinine more than 150 µmol/l)
  • 9. Malignant disease
  • 10. Kidney-stones (also when this occurs in the family), urinary tract infections
  • 11. Infectious diseases
  • 12. Use of antibiotics
  • 13. Use of any medication that influence T-lymphocytes or vitamin D metabolism
  • 14. Disease or use of any medication known to affect Ca metabolism or skeletal physiology
  • 15. Serious mental impairment i.e. preventing to understand the study protocol/aim

研究者

发起方
VU University Medical Center (The Netherlands)

相似试验

The effects of low dose 1,25-dihydroxyvitamin D3 on... | 临床试验